| 缩写名/全名 |
EXPERT REV MOL DIAGN
EXPERT REVIEW OF MOLECULAR DIAGNOSTICS |
||||||||||||||||||||||||||||
| ISSN号 | 1473-7159 | ||||||||||||||||||||||||||||
| 研究方向 | 医学-病理学 | ||||||||||||||||||||||||||||
| 影响因子 | 2015:3.333, 2016:3.1, 2017:3.326, 2018:3.099, 2019:4.096, | ||||||||||||||||||||||||||||
| 出版国家 | ENGLAND | ||||||||||||||||||||||||||||
| 出版周期 | Bimonthly | ||||||||||||||||||||||||||||
| 年文章数 | 93 | ||||||||||||||||||||||||||||
| 出版年份 | 2001 | ||||||||||||||||||||||||||||
| 是否OA | No | ||||||||||||||||||||||||||||
| 审稿周期(仅供参考) | 较慢,6-12周 |
||||||||||||||||||||||||||||
| 录用比例 | 一般 | ||||||||||||||||||||||||||||
| 投稿链接 | https://mc.manuscriptcentral.com/ero | ||||||||||||||||||||||||||||
| 投稿官网 | http://www.tandfonline.com/toc/iero20/current | ||||||||||||||||||||||||||||
| h-index | 68 | ||||||||||||||||||||||||||||
| CiteScore |
|
||||||||||||||||||||||||||||
| PubMed Central (PMC)链接 | http://www.ncbi.nlm.nih.gov/nlmcatalog?term=1473-7159%5BISSN%5D | ||||||||||||||||||||||||||||
| 中科院SCI期刊分区 （ 2018年新版本） |
|
||||||||||||||||||||||||||||
| 中科院SCI期刊分区 （ 2020年新版本） |
|
| 中国学者近期发表的论文 | |
| 1. | Advances in prognostic biomarkers for esophageal cancer. Author: Yang W1, Han Y2, Zhao X1, Duan L1, Zhou W1, Wang X1, Shi G3, Che Y3, Zhang Y1, Liu J1, Zhang H4, Zhao Q4, Hong L1, Fan D1. Journal: Expert Rev Mol Diagn. 2019 Feb;19(2):109-119. doi: 10.1080/14737159.2019.1563485. Epub 2018 Dec 30. PubMed DOI |
| 2. | Screening of fetal chromosomal aneuploidy diseases using noninvasive prenatal testing in twin pregnancies. Author: Yu W1,2, Lv Y1,2, Yin S1,2, Liu H1,2, Li X1,2, Liang B3, Kong L3, Liu C1,2. Journal: Expert Rev Mol Diagn. 2019 Feb;19(2):189-196. doi: 10.1080/14737159.2019.1562906. Epub 2019 Jan 2. PubMed DOI |
| 3. | Liquid biopsy in newly diagnosed patients with locoregional (I-IIIA) non-small cell lung cancer. Author: Chen K1, Kang G1, Zhao H1, Zhang K1, Zhang J1, Yang F1, Wang J1. Journal: Expert Rev Mol Diagn. 2019 May;19(5):419-427. doi: 10.1080/14737159.2019.1599717. Epub 2019 Apr 3. PubMed DOI |
| 4. | Advances in prognostic markers for colorectal cancer. Author: Duan L1, Yang W1, Wang X1, Zhou W1, Zhang Y1, Liu J1, Zhang H1, Zhao Q1, Hong L1, Fan D1. Journal: Expert Rev Mol Diagn. 2019 Apr;19(4):313-324. doi: 10.1080/14737159.2019.1592679. Epub 2019 Mar 25. PubMed DOI |
| 5. | MicroRNAs in rheumatoid arthritis: what is the latest with regards to diagnostics? Author: Huang RY1,2, Wu JQ1, Liu ZH1, Sun SL3. Journal: Expert Rev Mol Diagn. 2019 May;19(5):363-366. doi: 10.1080/14737159.2019.1599716. Epub 2019 Apr 8. PubMed DOI |
| 6. | Research progress and clinical application of predictive biomarker for immune checkpoint inhibitors. Author: Ma K1, Jin Q1, Wang M1, Li X1, Zhang Y1. Journal: Expert Rev Mol Diagn. 2019 Jun;19(6):517-529. doi: 10.1080/14737159.2019.1617702. Epub 2019 May 22. PubMed DOI |
| 7. | Screening, prenatal diagnosis, and prenatal decision for sex chromosome aneuploidy. Author: Xu Y1, Chen L1, Liu Y1, Hao Y1, Xu Z1, Deng L2, Xie J1. Journal: Expert Rev Mol Diagn. 2019 Jun;19(6):537-542. doi: 10.1080/14737159.2019.1613154. Epub 2019 May 13. PubMed DOI |
| 8. | Standardising HbA1c-based diabetes diagnosis: opportunities and challenges. Author: Jia W. Journal: Expert Rev Mol Diagn. 2016;16(3):343-55. doi: 10.1586/14737159.2016.1133299. Epub 2016 Jan 4. PubMed |
| 9. | Histone modifying enzymes: novel disease biomarkers and assay development. Author: Ma F, Zhang CY. Journal: Expert Rev Mol Diagn. 2016;16(3):297-306. doi: 10.1586/14737159.2016.1135057. Epub 2016 Jan 11. PubMed |
| 10. | Advances in addressing technical challenges of point-of-care diagnostics in resource-limited settings. Author: Wang S, Lifson MA, Inci F, Liang LG, Sheng YF, Demirci U. Journal: Expert Rev Mol Diagn. 2016 Apr;16(4):449-59. doi: 10.1586/14737159.2016.1142877. Epub 2016 Feb 24. PubMed |
|
|
